These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22116809)

  • 1. Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.
    Hartz AM; Bauer B; Soldner EL; Wolf A; Boy S; Backhaus R; Mihaljevic I; Bogdahn U; Klünemann HH; Schuierer G; Schlachetzki F
    Stroke; 2012 Feb; 43(2):514-23. PubMed ID: 22116809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of circulating human apolipoprotein J reduces the occurrence of cerebral microbleeds in a transgenic mouse model with cerebral amyloid angiopathy.
    Bonaterra-Pastra A; Solé M; Lope-Piedrafita S; Lucas-Parra M; Castellote L; Marazuela P; Pancorbo O; Rodríguez-Luna D; Hernández-Guillamon M
    Alzheimers Res Ther; 2024 Jul; 16(1):169. PubMed ID: 39069622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
    Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
    J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.
    Carrano A; Hoozemans JJ; van der Vies SM; Rozemuller AJ; van Horssen J; de Vries HE
    Antioxid Redox Signal; 2011 Sep; 15(5):1167-78. PubMed ID: 21294650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ₁₋₄₂-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca²⁺-calcineurin signaling.
    Kook SY; Hong HS; Moon M; Ha CM; Chang S; Mook-Jung I
    J Neurosci; 2012 Jun; 32(26):8845-54. PubMed ID: 22745485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier.
    Magaki S; Tang Z; Tung S; Williams CK; Lo D; Yong WH; Khanlou N; Vinters HV
    Neurobiol Aging; 2018 Oct; 70():70-77. PubMed ID: 30007166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
    Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
    Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: sporadic cerebral amyloid angiopathy.
    Attems J; Jellinger K; Thal DR; Van Nostrand W
    Neuropathol Appl Neurobiol; 2011 Feb; 37(1):75-93. PubMed ID: 20946241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
    Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
    Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase 9-mediated intracerebral hemorrhage induced by cerebral amyloid angiopathy.
    Zhao L; Arbel-Ornath M; Wang X; Betensky RA; Greenberg SM; Frosch MP; Bacskai BJ
    Neurobiol Aging; 2015 Nov; 36(11):2963-2971. PubMed ID: 26248866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice.
    Garcia-Alloza M; Prada C; Lattarulo C; Fine S; Borrelli LA; Betensky R; Greenberg SM; Frosch MP; Bacskai BJ
    J Neurochem; 2009 Jun; 109(6):1636-47. PubMed ID: 19457117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
    Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
    Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy.
    Carrano A; Hoozemans JJ; van der Vies SM; van Horssen J; de Vries HE; Rozemuller AJ
    Neurodegener Dis; 2012; 10(1-4):329-31. PubMed ID: 22301467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.
    Jang H; Jang YK; Kim HJ; Werring DJ; Lee JS; Choe YS; Park S; Lee J; Kim KW; Kim Y; Cho SH; Kim SE; Kim SJ; Charidimou A; Na DL; Seo SW
    Eur J Nucl Med Mol Imaging; 2019 Jun; 46(6):1287-1298. PubMed ID: 30937462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
    Gireud-Goss M; Mack AF; McCullough LD; Urayama A
    Neuroscientist; 2021 Dec; 27(6):668-684. PubMed ID: 33238806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy.
    Freeze WM; Bacskai BJ; Frosch MP; Jacobs HIL; Backes WH; Greenberg SM; van Veluw SJ
    Stroke; 2019 Feb; 50(2):328-335. PubMed ID: 30661497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
    Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
    Bell RD; Zlokovic BV
    Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.